Prothena Corp Public (PRTA) Capital Expenditures (2012 - 2025)

Prothena Corp Public (PRTA) recorded quarterly Capital Expenditures of $10000.0 in Q3 2025, down 88.37% quarter-over-quarter from $86000.0 in Q2 2025, and up 11.11% on a YoY basis from $9000.0 in Q3 2024.

Prothena Corp Public (PRTA) Capital Expenditures (2012 - 2025) Analysis & Trends

Prothena Corp Public's Capital Expenditures history runs 14 years deep, the most recent figure standing at $10000.0 for Q3 2025.

  • In Q3 2025, Capital Expenditures rose 11.11% year-over-year to $10000.0; the TTM figure through Mar 2026 stood at $96000.0 (down 59.49% YoY), while the FY2025 annual figure was $138000.0, down 53.69% from the prior year.
  • Capital Expenditures was $10000.0 for Q3 2025 at Prothena Corp Public, down from $86000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.5 million in Q4 2023 to a low of $9000.0 in Q3 2024.
  • Historically, Capital Expenditures has averaged $238055.6 across 5 years, with a median of $116500.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Capital Expenditures surged 925.83% in 2023, then sank 97.96% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $319000.0 in 2021, then sank by 52.66% to $151000.0 in 2022, then soared by 925.83% to $1.5 million in 2023, then slumped by 97.22% to $43000.0 in 2024, then slumped by 76.74% to $10000.0 in 2025.
  • The last three Capital Expenditures figures came in at $10000.0 (Q3 2025), $86000.0 (Q2 2025), and $42000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 Prothena Corp Public 479.08 Mn 149.61 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 10,000.00
Sep 30, 2025 10,000.00
Jun 30, 2025 86,000.00
Jun 30, 2025 86,000.00
Mar 31, 2025 42,000.00
Mar 31, 2025 42,000.00
Dec 31, 2024 43,000.00
Dec 31, 2024 43,000.00
Sep 30, 2024 9,000.00
Sep 30, 2024 9,000.00
Jun 30, 2024 143,000.00
Jun 30, 2024 143,000.00
Mar 31, 2024 103,000.00
Mar 31, 2024 103,000.00
Dec 31, 2023 1.55 Mn
Dec 31, 2023 1.55 Mn
Sep 30, 2023 442,000.00
Sep 30, 2023 442,000.00
Jun 30, 2023 771,000.00
Jun 30, 2023 771,000.00